These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 154771)

  • 1. [Disorders of phenylalanine and tyrosine metabolism in Down's syndrome].
    Shaposhnikov AM; Khal'chitskiĭ SE; Shvarts EI
    Vopr Med Khim; 1979; 25(1):15-9. PubMed ID: 154771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders in the phenylalanine hydroxylase system of the liver in alcoholism].
    Shaposhnikov AM; Skachkov MM
    Vopr Med Khim; 1977; 23(4):495-9. PubMed ID: 919373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical study of malnutrition. Part V. Metabolism of phenylalanine and tyrosine.
    Antener I; Verwilghen AM; van Geert C; Mauron J
    Int J Vitam Nutr Res; 1981; 51(3):297-306. PubMed ID: 6119298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenylalanine-4-hydroxylase activity in the liver in viral hepatitis].
    Shaposhnikova AM; Skachkov MM; Babitskiĭ GIa
    Vopr Med Khim; 1977; 23(5):597-601. PubMed ID: 595492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased phenylalanine uptake and turnover in patients with vitiligo.
    Schallreuter KU; Chavan B; Rokos H; Hibberts N; Panske A; Wood JM
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S27-33. PubMed ID: 16143555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
    Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration and composition of cerebral gangliosides in Down's disease].
    Karpova OB; Obukhova EL; Avrova NF; Shvartz EI
    Vopr Med Khim; 1978; 24(4):524-7. PubMed ID: 150702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of deutero-L-phenylalanine and deutero-L-tyrosine in normal and in various tumor-bearing rats.
    Ziegler I; Kokolis N; Stichler W
    Cancer Biochem Biophys; 1977; 2(2):71-7. PubMed ID: 616324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.
    Thompson GN; Halliday D
    J Clin Invest; 1990 Jul; 86(1):317-22. PubMed ID: 2365821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free amino acid pool in the brain of mice homozygous for the gene "dilute lethal".
    Simler S; Essayag S; Ledig M; Koehl C; Mandel P
    J Neurosci Res; 1977; 3(4):281-7. PubMed ID: 566796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.
    van Spronsen FJ; Reijngoud DJ; Smit GP; Nagel GT; Stellaard F; Berger R; Heymans HS
    J Clin Invest; 1998 Jun; 101(12):2875-80. PubMed ID: 9637722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics.
    Curtius HC; Zagalak MJ; Baerlocher K; Schaub J; Leimbacher W; Redweik U
    Helv Paediatr Acta; 1978 Feb; 32(6):461-9. PubMed ID: 632110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the levels of phenylalanine, tyrosine and tetrahydrobiopterin in the blood of tumor-bearing organisms.
    Kokolis N; Ziegler I
    Cancer Biochem Biophys; 1977; 2(2):79-85. PubMed ID: 616325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free plasma and cerebral amino acids in children with Down's syndrome].
    Abasheva GK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1068-70. PubMed ID: 6457478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylalanine metabolism in uremic and normal man.
    Jones MR; Kopple JD; Swendseid ME
    Kidney Int; 1978 Aug; 14(2):169-79. PubMed ID: 357810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism.
    Tessari P; Vettore M; Millioni R; Puricelli L; Orlando R
    Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):81-6. PubMed ID: 19898234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.